Your browser doesn't support javascript.
loading
Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
Kinoshita, Yoshikazu; Kato, Mototsugu; Fujishiro, Mitsuhiro; Masuyama, Hironori; Nakata, Ryo; Abe, Hisanori; Kumagai, Shinji; Fukushima, Yasushi; Okubo, Yoshiumi; Hojo, Seiichiro; Kusano, Motoyasu.
Afiliação
  • Kinoshita Y; Department of Internal Medicine II, Faculty of Medicine, Shimane University, 89-1, Enya-cho, Izumo, Shimane, 693-8501, Japan. kinosita@med.shimane-u.ac.jp.
  • Kato M; Department of Gastroenterology, National Hospital Organization Hakodate Hospital, Hakodate, Hokkaido, Japan.
  • Fujishiro M; Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Masuyama H; Masuyama Gastrointestinal Clinic, Ohtawara, Tochigi, Japan.
  • Nakata R; Japanese Red Cross Medical Center, Tokyo, Japan.
  • Abe H; Arita GI Hospital, Oita, Oita, Japan.
  • Kumagai S; Nakajima Hospital, Sendai, Miyagi, Japan.
  • Fukushima Y; Tokyo-Eki Center-Building Clinic, Tokyo, Japan.
  • Okubo Y; Clinical Development Department, EA Pharma Co., Ltd, Tokyo, Japan.
  • Hojo S; Clinical Data Science Department, Eisai Co., Ltd, Tokyo, Japan.
  • Kusano M; Department of Gastroenterology, Gunma University Hospital, Maebashi, Gunma, Japan.
J Gastroenterol ; 53(7): 834-844, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29188387

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esofagite Péptica / Refluxo Gastroesofágico / Inibidores da Bomba de Prótons / Rabeprazol / Antiulcerosos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esofagite Péptica / Refluxo Gastroesofágico / Inibidores da Bomba de Prótons / Rabeprazol / Antiulcerosos Idioma: En Ano de publicação: 2018 Tipo de documento: Article